PHARMA
Quarterly rpt on consolidated results for the financial period ended 30/9/2005
| PHARMANIAGA BERHAD |
|
Quarterly report for the financial period ended | 30/09/2005 |
| Quarter | 3 |
| Financial Year End | 31/12/2005 |
| The figures | have not been audited |
SUMMARY OF KEY FINANCIAL INFORMATION30/09/2005 |
INDIVIDUAL PERIOD | CUMULATIVE PERIOD | ||||
CURRENT YEAR QUARTER | PRECEDING YEAR CORRESPONDING QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR CORRESPONDING PERIOD | ||
30/09/2005 | 30/09/2004 | 30/09/2005 | 30/09/2004 | ||
RM'000 | RM'000 | RM'000 | RM'000 | ||
| 1 | Revenue | 221,566 | 229,265 | 692,222 | 599,214 |
| 2 | Profit/(loss) before tax | 8,854 | 22,581 | 41,415 | 59,514 |
| 3 | Profit/(loss) after tax and minority interest | 6,480 | 14,201 | 25,890 | 37,467 |
| 4 | Net profit/(loss) for the period | 6,480 | 14,201 | 25,890 | 37,467 |
| 5 | Basic earnings/(loss) per share (sen) | 6.23 | 13.99 | 25.19 | 37.06 |
| 6 | Dividend per share (sen) | 0.00 | 0.00 | 0.00 | 4.50 |
AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | ||||
| 7 | Net tangible assets per share (RM) | 2.6500 | 2.6000 | ||
Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my
| Remarks : |
| For the current financial period ended 30 September 2005, the Board of Directors is recommending an interim tax exempt dividend of 3.5 sen per share (2004:interim tax exempt dividend of 4.5 sen on 101,606,267 ordinary shares of RM1.00 each amounting to RM4,572,282 was paid on 19 October 2004). The date of book closure will be announced in due course. |
Announcement Info
| Company Name | PHARMANIAGA BERHAD |
| Stock Name | PHARMA |
| Date Announced | 22 Nov 2005 |
| Category | Financial Results |
| Reference No | CC-051116-37552 |